Nr.Numele studiuluiStatusLocatia/Locatiile studiului
1Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) (QuANTUM-First)Activ, inca nu se recruteazaInstitutul Regional de Oncologie Iași, Iași, Romania, 20125Spitalul Clinic Colentina, Bucuresti, Romania, 20125Spitalul Clinic Coltea, Bucuresti, Romania, 20125Spitalul Universitar de Urgenta Bucuresti, Bucuresti, Romania, 20125Institutul Clinic Fundeni, Bucuresti, Romania, 22328Institutul Oncologic „Prof. Dr. Ion Chiricuţă” Cluj Napoca, Cluj-Napoca, Romania, 400124Spitalul Clinic Municipal Filantropia Craiova, Craiova, Romania, 200143Spitalul Clinic Judetean de Urgenta Târgu-Mureş (4005), Târgu-Mureş, Romania, 540042Spitalul Clinic Judetean de Urgenta Târgu-Mureş (4008), Târgu-Mureş, Romania, 540136
2A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia (BRIGHT AML1019)Activ, inca nu se recruteazaInstitutul Oncologic ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Cluj, Romania, 400124Spitalul Clinic Municipal Filantropia Craiova, Sectia Clinica Hematologie, Craiova, Dolj, Romania, 200136Spitalul Universitar de Urgenta Militar Central „Dr. Carol Davila” Bucuresti, Bucuresti, Romania, 010825Spitalul Clinic Coltea, Clinica de Hematologie, Bucuresti, Romania, 030171
3Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Monotherapy in Patients With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia.Acitv, inca nu se recruteazaNovartis Investigative Site, Bucharest, District 2, Romania, 022328Novartis Investigative Site, Tg Mures, Mures, Romania, 540136Novartis Investigative Site, Craiova, Romania, 200136Novartis Investigative Site, Iasi, Romania, 700483
4A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete RemissionActiv, inca nu se recruteazaSite RO40005, București, Romania
5Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIsActiv, inca nu se recruteazaNovartis Investigative Site, Bucharest, District 2, Romania, 022328Novartis Investigative Site, Bucharest, Romania, 030171Novartis Investigative Site, Cluj-Napoca, Romania, 400124Novartis Investigative Site, Craiova, Romania, 200136Novartis Investigative Site, Timisoara, Romania, 300079
6Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HR First Relapse B-precursor ALLActiv, inca nu se recruteazaResearch Site, Bucharest, Romania, 022328Research Site, Cluj-Napoca, Romania, 400177
7Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic LeukaemiaIn curs de recrutareInsitutul Clinic Fundeni, Sectia de Transplant Medular, Bucharest, Romania, Contact: Anca Colita, MD PhD, Principal Investigator: Anca Colita, MD PhD         University of Medicine and Pharmacy V. BABES, Emergency Children’s Hospital LOUIS TURCANU, III. Clinic of Pediatrics , Department of Onco-hematology and Bone Marrow Transplantation, Timişoara, Romania, Contact: Cristian Jinca, MD PhD,   Principal Investigator: Cristian Jinca, MD PhD  
8A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line TherapyActiv, inca nu se recruteazaInstitutul Clinic Fundeni, Bucharest, Romania, 022328Spitalul Clinic Coltea, Bucharest, Romania, 030171Spitalul Clinic Judetean de Urgenta Sf Spiridon Iasi   , Iasi, Romania, 700111Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu, Romania, 550245Spitalul Clinic Municipal de Urgenta Timisoara, Timisoara, Romania, 300079
9A Study to Compare the Efficacy and Safety of Obinutuzumab + Venetoclax (GDC-0199) Versus Obinutuzumab + Chlorambucil in Participants With Chronic Lymphocytic LeukemiaActiv, inca nu se recruteazaFundeni Clinical Inst. ; Hematology Dept., Bucharest, Romania, 022328Institutul Regional de Oncologie Iasi; Clinica de Hematologie, Iasi, Romania, 700483Spitalul Clinic Judetean de Urgenta Targu-Mures; compartiment Hematologie, Targu-mures, Romania, 540136
10A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to ImatinibActiv, inca nu se recruteazaLocal Institution, Bucharest, Romania, 022322
11Safety, Tolerability, Pharmacokinetics and Activity of K0706In curs de recrutareSpitalul Clinic Colentina Recruiting Bucuresti, Romania, 020125 Spitalul Clinic Coltea Recruiting Bucuresti, Romania, 030171 Institutul Oncologic „Prof. Dr. Ion Chiricuta” Cluj-Napoca Recruiting Cluj-Napoca, Romania, 400124 Spitalul Clinic Municipal Filantropia Craiova Recruiting Craiova, Romania, 200143 Spitalul Clinic Judetean de Urgenta Targu Mures Recruiting Târgu Mureș, Romania, 540136
12An Efficacy Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Participants With Newly Diagnosed Ph+ ALLIn curs de recrutareSpitalul Clinic Municipal de Urgenta Timisoara Recruiting Timisoara, Timis, Romania, 300021 Spitalul Clinic Colentina Recruiting Bucuresti, Romania, 020125 Spitalul Universitar de Urgenta Bucuresti Recruiting Bucuresti, Romania, 50098 Institutul Regional de Oncologie Iasi Recruiting Iasi, Romania, 700483
(Visited 18 times, 1 visits today)